Airway diseases comprise a broad range of chronic lung diseases which are of interest to a wide variety of respiratory specialists, from clinicians and allied health professionals, to scientists and researchers.
The ERS International Congress programme includes a dedicated airway diseases track that has been developed by experts in the field. The track includes a variety of activities for health professionals who are involved in the management of patients with airway diseases and for researchers with an interest in this disease area.
Q: What are you most looking forward to at this year’s Congress in the airway diseases field?
A: Within our Assembly, there has been real energy from all the officers this year to put together a really strong and special programme for the Congress in the airway diseases field, especially as it has been 3 years since we all last met on site in 2019. Do try to attend the Assembly 5 members’ meeting where we would welcome your thoughts and ideas for next year’s Congress, which we are already planning.
Q: Is there a specific session in this track that should not be missed?
A: My top 4 picks for this year are
Q: What does Congress offer to early career professionals who specialise in airway diseases?
A: After a long wait, we return to the face-to-face Congress with a lot of enthusiasm. The ERS Congress is a great opportunity for early career professionals whose training has been affected by the pandemic to update their knowledge, learn about ERS-sponsored fellowship options and, of course, meet people. We have many interesting sessions, but the ones not to miss are: the State of the art session “Precision medicine for asthma, COPD and chronic cough: New drugs, new biomarkers and new approaches”, where we will have the opportunity to hear from experts in COPD and, of course, the session on Guidelines: “ERS clinical practice guidelines on the diagnosis of asthma in adults” useful in clinical practice.